Research location
Choceň
Czechia
Advertisement
Research activity in Choceň
CzechiaCureCurrent currently publishes aggregate city-level research activity for this location: 40 trials and 42 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Choceň
40 linked trials · page 1 of 1A Study of Orelabrutinib in Patients With Secondary Progressive Multiple SclerosisNCT07299019 · 2026-03-23 · 1 site observation
RECRUITING
A Study of Orelabrutinib in Patients With Primary Progressive Multiple SclerosisNCT07067463 · 2026-03-23 · 1 site observation
RECRUITING
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)NCT06937229 · 2025-12-02 · 1 site observation
RECRUITING
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease PsychosisNCT06887192 · 2025-08-15 · 1 site observation
RECRUITING
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's DiseaseNCT07011745 · 2025-07-16 · 1 site observation
RECRUITING
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's DementiaNCT06651567 · 2024-10-22 · 1 site observation
RECRUITING
ACP-204 in Adults With Alzheimer's Disease PsychosisNCT06159673 · 2023-11-14 · 1 site observation
RECRUITING
Phase 3, Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of AR1001 in Participants With Early Alzheimer's Disease (Polaris-AD)NCT05531526 · 2022-12-23 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Learn How Safe BAY2395840 is and How Well it Works in Participants Who Have Diabetic Nerve PainNCT05219812 · 2022-02-16 · 1 site observation
COMPLETED
Evaluation of the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Participants With Multiple SclerosisNCT04984278 · 2021-08-16 · 1 site observation
TERMINATED
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)NCT04777396 · 2021-05-18 · 1 site observation
COMPLETED
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)NCT04777409 · 2021-05-18 · 1 site observation
COMPLETED
A 2-part Trial to Learn More About How BAY1817080 Works, How Safe it is, and What the Right Dose is for Participants With Diabetic Neuropathic PainNCT04641273 · 2021-01-22 · 1 site observation
TERMINATED
Trial to Evaluate the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Participants With Multiple SclerosisNCT04657666 · 2020-12-21 · 1 site observation
COMPLETED
A Study to Evaluate the Efficacy and Safety of Fremanezumab for Preventive Treatment of Migraine in Patients With Major Depressive DisorderNCT04041284 · 2019-09-13 · 1 site observation
COMPLETED
Open Label Extension (OLE) Study of the Safety and Clinical Utility of IPX203 in Parkinson's Disease (PD) Participants With Motor FluctuationsNCT03877510 · 2019-04-03 · 1 site observation
COMPLETED
BX-1 in Spasticity Due to Multiple SclerosisNCT03756974 · 2019-02-18 · 1 site observation
COMPLETED
A Study to Evaluate the Safety and Efficacy of IPX203 in Parkinson's Disease Participants With Motor FluctuationsNCT03670953 · 2018-11-06 · 1 site observation
COMPLETED
Evaluation of Quality of Life (QoL) in Subjects With Highly Active Relapsing Multiple Sclerosis (MS) (CLARIFY MS)NCT03369665 · 2018-06-20 · 1 site observation
COMPLETED
Evaluation of the Onset of Action in Highly Active MS (MAGNIFY)NCT03364036 · 2018-05-28 · 1 site observation
COMPLETED
Proof-of-Concept Study of a Selective p38 MAPK Alpha Inhibitor, Neflamapimod, in Subjects With Mild Alzheimer's DiseaseNCT03402659 · 2017-12-29 · 1 site observation
COMPLETED
Trazodone in Painful Diabetic NeuropathyNCT03202979 · 2017-05-16 · 1 site observation
COMPLETED
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)NCT03071692 · 2017-03-23 · 1 site observation
TERMINATED
A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease DementiaNCT02783573 · 2016-07-01 · 1 site observation
TERMINATED
A Long Term Safety Study of ND0612 Administered as a Continuous SC Infusion in Advanced Parkinson's DiseaseNCT02726386 · 2016-05-04 · 1 site observation
ACTIVE_NOT_RECRUITING
Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's DiseaseNCT02547818 · 2015-09-15 · 1 site observation
COMPLETED
Safety and Efficacy Study of Tozadenant to Treat End of Dose Wearing Off in Parkinson's PatientsNCT02453386 · 2015-07-01 · 1 site observation
TERMINATED
Randomized Safety Study of CVT-301 Compared to an Observational Control GroupNCT02352363 · 2015-03-01 · 1 site observation
COMPLETED
Efficacy and Safety Study of Prolonged-Release Fampridine in Participants With Multiple SclerosisNCT02219932 · 2014-09-01 · 1 site observation
COMPLETED
Long-term Safety and Tolerability of Idalopirdine (Lu AE58054) as Adjunctive Treatment to Donepezil in Patients With Mild-moderate Alzheimer's DiseaseNCT02079246 · 2014-04-07 · 1 site observation
COMPLETED
Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With an Acetylcholinesterase InhibitorNCT02006654 · 2014-03-01 · 2 site observations
COMPLETED
Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic NephropathyNCT02065791 · 2014-02-17 · 1 site observation
COMPLETED
Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With DonepezilNCT02006641 · 2014-02-01 · 2 site observations
COMPLETED
Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's DiseaseNCT01969136 · 2013-10-01 · 1 site observation
TERMINATED
Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)NCT01897532 · 2013-07-10 · 1 site observation
COMPLETED
A Study of RO4602522 in Participants With Moderate Severity Alzheimer Disease on Background Alzheimer Disease TherapyNCT01677754 · 2012-10-24 · 1 site observation
COMPLETED
Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular DiseaseNCT01609582 · 2012-06-01 · 1 site observation
TERMINATED
Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 DiabetesNCT01481116 · 2012-01-01 · 1 site observation
TERMINATED
Efficacy, Safety, & Tolerability of AZD3480 Patients With Mild to Moderate Dementia of the Alzheimer's Type (AD)NCT01466088 · 2011-10-01 · 1 site observation
COMPLETED
A Randomised Placebo Controlled Study of OXN PR for Severe Parkinson's Disease Associated PainNCT01439100 · 2011-10-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.